{"ticker": {"uuid": "c7c283ff-2c34-4ea9-b775-1ba4cd1e9c0c", "symbol": "QIA", "name": "Qiagen N.V.", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel", "summary": "QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour FDA clearance marks QIAGEN's entry into U.S. bloodstream infection testing and establishes the first member of a planned QIAstat-Dx BCID panel family Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting about 1.7 million adults annually in the U.S., underscoring the need for rapid detection GERMANTOWN, Md. & VENLO, Netherlands, August 10, 2026--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard:", "url": "https://finance.yahoo.com/healthcare/articles/qiagen-receives-u-fda-clearance-200500942.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T20:05:00+00:00", "published_display": "10 Aug 2026 20:05", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.331, "duplicate_count": 1, "topics": ["Antimicrobial Resistance", "Diagnostics", "Dividend Payments", "Earnings Per Share", "Fda Approval", "Infectious Diseases"]}, {"title": "Understanding Qiagen (QGEN) Reliance on International Revenue", "summary": "Have you assessed how the international operations of Qiagen (QGEN) performed in the quarter ended June 2026? For this diagnostic products maker, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects. The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become essential for investors to comprehend how much a company relies on these foreign markets, as this unde", "url": "https://finance.yahoo.com/markets/stocks/articles/understanding-qiagen-qgen-reliance-international-131511002.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T13:15:11+00:00", "published_display": "10 Aug 2026 13:15", "sentiment": "positive", "sentiment_pct": 78, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.258, "duplicate_count": 1, "topics": ["Consensus Estimate", "Earnings", "Earnings Estimate", "International Revenue", "Medical Sector", "Total Revenue"]}], "by_tier": {"direct": [{"title": "QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel", "summary": "QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour FDA clearance marks QIAGEN's entry into U.S. bloodstream infection testing and establishes the first member of a planned QIAstat-Dx BCID panel family Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting about 1.7 million adults annually in the U.S., underscoring the need for rapid detection GERMANTOWN, Md. & VENLO, Netherlands, August 10, 2026--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard:", "url": "https://finance.yahoo.com/healthcare/articles/qiagen-receives-u-fda-clearance-200500942.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T20:05:00+00:00", "published_display": "10 Aug 2026 20:05", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.331, "duplicate_count": 1, "topics": ["Antimicrobial Resistance", "Diagnostics", "Dividend Payments", "Earnings Per Share", "Fda Approval", "Infectious Diseases"]}, {"title": "Understanding Qiagen (QGEN) Reliance on International Revenue", "summary": "Have you assessed how the international operations of Qiagen (QGEN) performed in the quarter ended June 2026? For this diagnostic products maker, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects. The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become essential for investors to comprehend how much a company relies on these foreign markets, as this unde", "url": "https://finance.yahoo.com/markets/stocks/articles/understanding-qiagen-qgen-reliance-international-131511002.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T13:15:11+00:00", "published_display": "10 Aug 2026 13:15", "sentiment": "positive", "sentiment_pct": 78, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.258, "duplicate_count": 1, "topics": ["Consensus Estimate", "Earnings", "Earnings Estimate", "International Revenue", "Medical Sector", "Total Revenue"]}], "industry": [], "sector": []}, "total_fetched": 2, "total_unique": 2, "total_relevant": 2, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 185, "call_budget": 500, "budget_used_pct": 37.0, "requests_made": 37, "last_success_at": "2026-08-13T05:00:28.226703+00:00", "newest_seen_at": "2026-08-13T04:31:14+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3530, "unmapped_mentions": 1787}, "status": "healthy"}, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 0, "score": 63, "raw_score": 77, "total": 2, "evidence_count": 2, "effective_articles": 1.97, "direct_story_count": 2, "industry_story_count": 0, "sector_story_count": 0, "story_count": 2, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 1, "confidence": 52, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-10T20:05:00+00:00", "label": "Constructive news tone", "tone": "positive"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 75, "events": [{"event": "earnings", "label": "Earnings", "weight": 1.2, "count": 2}], "positive_events": 2, "negative_events": 0, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 185, "call_budget": 500, "budget_used_pct": 37.0, "requests_made": 37, "last_success_at": "2026-08-13T05:00:28.226703+00:00", "newest_seen_at": "2026-08-13T04:31:14+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3530, "unmapped_mentions": 1787}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 36.46, "latest_week": "2026-08-07", "one_week_move": 2.1, "four_week_move": 0.2, "twelve_week_move": 28.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.89262, "market_dynamics_buy_signal": false, "relative_strength": -10.01475, "fair_value_gap": -5.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.843, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.1% over one week, +0.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "News confirmed by price", "tone": "positive", "classification": "confirmed_positive", "summary": "Constructive news tone is being confirmed by positive weekly price action.", "confidence": 64, "badges": ["Sentiment-trend disagreement"], "opportunities": [], "risks": ["Positive news is arriving while the Sharemaestro trend signal is inactive."], "event_label": "Earnings", "sentiment_word": "constructive"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "63/100", "tone": "positive", "text": "Constructive news tone"}, {"label": "Evidence confidence", "value": "52/100", "tone": "neutral", "text": "1.97 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "News confirmed by price", "tone": "positive", "text": "Constructive news tone is being confirmed by positive weekly price action."}, {"label": "Primary event", "value": "Earnings", "tone": "positive", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "1/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.1% over one week, +0.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel"}], "updated_at": "2026-08-13T05:05:27.001272+00:00", "detail_intelligence": {"headline": "News confirmed by price", "summary": "Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 63, "display": "63", "tone": "positive", "note": "Constructive news tone"}, {"label": "Evidence confidence", "value": 52, "display": "52", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "2 direct stories"}, {"label": "Evidence agreement", "value": 99, "display": "99", "tone": "positive", "note": "1/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 25, "note": "1.97 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 65, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 99, "note": "cross-story consistency"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 65, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 683.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 2, "score": 77, "tone": "positive", "x": 820.6, "y": 85.9, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 0, "score": null, "tone": "neutral", "x": 866.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "820.6,85.9", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Establishing", "tone": "neutral", "recent_score": 77, "prior_score": null, "delta": null, "recent_count": 2, "prior_count": 0, "volume_delta": 2}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 2, "share": 100}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 2, "share": 100, "score": 77, "tone": "positive"}], "event_profile": [{"label": "Earnings", "count": 2, "share": 100, "score": 77, "tone": "positive"}], "topics": [{"label": "Total Revenue", "count": 1, "share": 50}, {"label": "Medical Sector", "count": 1, "share": 50}, {"label": "International Revenue", "count": 1, "share": 50}, {"label": "Infectious Diseases", "count": 1, "share": 50}, {"label": "Fda Approval", "count": 1, "share": 50}, {"label": "Earnings Per Share", "count": 1, "share": 50}, {"label": "Earnings Estimate", "count": 1, "share": 50}, {"label": "Earnings", "count": 1, "share": 50}, {"label": "Dividend Payments", "count": 1, "share": 50}, {"label": "Diagnostics", "count": 1, "share": 50}], "supporting": [{"label": "Direct evidence", "text": "2 current stories are mapped specifically to QIA."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 99/100, indicating a comparatively coherent tape."}, {"label": "Price response", "text": "Constructive news tone is being confirmed by positive weekly price action."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel", "summary": "QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour FDA clearance marks QIAGEN's entry into U.S. bloodstream infection testing and establishes the first member of a planned QIAstat-Dx BCID panel family Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting about 1.7 million adults annually in the U.S., underscoring the need for rapid detection GERMANTOWN, Md. & VENLO, Netherlands, August 10, 2026--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard:", "url": "https://finance.yahoo.com/healthcare/articles/qiagen-receives-u-fda-clearance-200500942.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T20:05:00+00:00", "published_display": "10 Aug 2026 20:05", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.334, "duplicate_count": 1, "topics": ["Antimicrobial Resistance", "Diagnostics", "Dividend Payments", "Earnings Per Share", "Fda Approval", "Infectious Diseases"]}, "article_count": 2, "updated_at": "2026-08-13T03:49:22.936254+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 55.8, "label": "13 Feb 2026", "close": 43.28, "index": 100.0}, {"x": 78.6, "y": 78.3, "label": "20 Feb 2026", "close": 40.99, "index": 94.7}, {"x": 115.3, "y": 68.7, "label": "27 Feb 2026", "close": 41.96, "index": 97.0}, {"x": 151.9, "y": 96.8, "label": "06 Mar 2026", "close": 39.1, "index": 90.3}, {"x": 188.6, "y": 126.7, "label": "13 Mar 2026", "close": 36.03, "index": 83.3}, {"x": 225.2, "y": 138.7, "label": "20 Mar 2026", "close": 34.8, "index": 80.4}, {"x": 261.8, "y": 147.1, "label": "27 Mar 2026", "close": 33.95, "index": 78.4}, {"x": 298.5, "y": 133.8, "label": "03 Apr 2026", "close": 35.31, "index": 81.6}, {"x": 335.1, "y": 136.4, "label": "10 Apr 2026", "close": 35.04, "index": 81.0}, {"x": 371.8, "y": 133.4, "label": "17 Apr 2026", "close": 35.35, "index": 81.7}, {"x": 408.4, "y": 160.5, "label": "24 Apr 2026", "close": 32.58, "index": 75.3}, {"x": 445.0, "y": 195.2, "label": "01 May 2026", "close": 29.04, "index": 67.1}, {"x": 481.7, "y": 204.2, "label": "08 May 2026", "close": 28.11, "index": 65.0}, {"x": 518.3, "y": 200.8, "label": "15 May 2026", "close": 28.46, "index": 65.8}, {"x": 555.0, "y": 182.9, "label": "22 May 2026", "close": 30.29, "index": 70.0}, {"x": 591.6, "y": 169.7, "label": "29 May 2026", "close": 31.64, "index": 73.1}, {"x": 628.2, "y": 170.2, "label": "05 Jun 2026", "close": 31.59, "index": 73.0}, {"x": 664.9, "y": 169.6, "label": "12 Jun 2026", "close": 31.65, "index": 73.1}, {"x": 701.5, "y": 168.1, "label": "19 Jun 2026", "close": 31.8, "index": 73.5}, {"x": 738.2, "y": 147.0, "label": "26 Jun 2026", "close": 33.96, "index": 78.5}, {"x": 774.8, "y": 144.0, "label": "03 Jul 2026", "close": 34.27, "index": 79.2}, {"x": 811.4, "y": 123.1, "label": "10 Jul 2026", "close": 36.4, "index": 84.1}, {"x": 848.1, "y": 127.4, "label": "17 Jul 2026", "close": 35.97, "index": 83.1}, {"x": 884.7, "y": 123.8, "label": "24 Jul 2026", "close": 36.33, "index": 84.0}, {"x": 921.4, "y": 129.8, "label": "31 Jul 2026", "close": 35.72, "index": 82.5}, {"x": 958.0, "y": 122.5, "label": "07 Aug 2026", "close": 36.46, "index": 84.2}], "sentiment_points": [{"x": 710.5, "y": 135.5, "label": "20 Jun 2026", "score": 47}, {"x": 710.9, "y": 135.5, "label": "20 Jun 2026", "score": 47}, {"x": 719.2, "y": 133.7, "label": "22 Jun 2026", "score": 48}, {"x": 719.8, "y": 133.7, "label": "22 Jun 2026", "score": 48}, {"x": 720.1, "y": 133.7, "label": "22 Jun 2026", "score": 48}, {"x": 721.2, "y": 133.7, "label": "22 Jun 2026", "score": 48}, {"x": 733.3, "y": 130.0, "label": "25 Jun 2026", "score": 50}, {"x": 740.5, "y": 133.7, "label": "26 Jun 2026", "score": 48}, {"x": 753.3, "y": 128.2, "label": "28 Jun 2026", "score": 51}, {"x": 765.0, "y": 130.0, "label": "01 Jul 2026", "score": 50}, {"x": 773.9, "y": 126.3, "label": "02 Jul 2026", "score": 52}, {"x": 778.4, "y": 124.5, "label": "03 Jul 2026", "score": 53}, {"x": 795.7, "y": 124.5, "label": "06 Jul 2026", "score": 53}, {"x": 815.1, "y": 124.5, "label": "10 Jul 2026", "score": 53}, {"x": 818.5, "y": 124.5, "label": "11 Jul 2026", "score": 53}, {"x": 821.3, "y": 124.5, "label": "11 Jul 2026", "score": 53}, {"x": 863.2, "y": 124.5, "label": "19 Jul 2026", "score": 53}, {"x": 867.6, "y": 126.3, "label": "20 Jul 2026", "score": 52}, {"x": 867.9, "y": 126.3, "label": "20 Jul 2026", "score": 52}, {"x": 868.0, "y": 126.3, "label": "20 Jul 2026", "score": 52}, {"x": 874.4, "y": 126.3, "label": "22 Jul 2026", "score": 52}, {"x": 875.6, "y": 128.2, "label": "22 Jul 2026", "score": 51}, {"x": 879.0, "y": 128.2, "label": "22 Jul 2026", "score": 51}, {"x": 881.4, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 882.4, "y": 128.2, "label": "23 Jul 2026", "score": 51}, {"x": 882.6, "y": 128.2, "label": "23 Jul 2026", "score": 51}, {"x": 887.7, "y": 128.2, "label": "24 Jul 2026", "score": 51}, {"x": 918.7, "y": 124.5, "label": "30 Jul 2026", "score": 53}], "price_path": "42.0,55.8 78.6,78.3 115.3,68.7 151.9,96.8 188.6,126.7 225.2,138.7 261.8,147.1 298.5,133.8 335.1,136.4 371.8,133.4 408.4,160.5 445.0,195.2 481.7,204.2 518.3,200.8 555.0,182.9 591.6,169.7 628.2,170.2 664.9,169.6 701.5,168.1 738.2,147.0 774.8,144.0 811.4,123.1 848.1,127.4 884.7,123.8 921.4,129.8 958.0,122.5", "sentiment_path": "710.5,135.5 710.9,135.5 719.2,133.7 719.8,133.7 720.1,133.7 721.2,133.7 733.3,130.0 740.5,133.7 753.3,128.2 765.0,130.0 773.9,126.3 778.4,124.5 795.7,124.5 815.1,124.5 818.5,124.5 821.3,124.5 863.2,124.5 867.6,126.3 867.9,126.3 868.0,126.3 874.4,126.3 875.6,128.2 879.0,128.2 881.4,126.3 882.4,128.2 882.6,128.2 887.7,128.2 918.7,124.5", "price_change": -15.8, "sentiment_change": 6, "latest_close": 36.46, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}